We make health research accessible to everyone, everywhere

We make health research accessible to
everyone, everywhere

Join our community

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Headshot Hayley Holt

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Headshot Ece Kavalci

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Headhshot Meri Beckwith

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.

Headshot Rebbeca de Rome

Why participate?

New treatments would not be possible without volunteers like you. By joining our community you will get access to clinical trials that a right for you

Help discover cutting edge new treatments
Benefit from treatments not available elsewhere
Learn about your health and medical conditions

Our active studies

Wise Therapeutics: Social Anxiety Study

READ MORE

The study aims to evaluate Wise Therapeutics’ mobile game as a treatment for social anxiety (anxiety experienced in relation to social situations) in people aged 18-65 years old. The study will be conducted completely remotely.

This study is registered on clinicaltrials.gov and co-sponsored by Hunter College of City University of New York.

Study For

US-based individuals aged 18-65 years old, with symptoms of social anxiety.

Sponsored By

Wise Therapeutics & Hunter College, The City University of New York

Participants

150

People

Take Part

Deadline:

December 31, 2022

CFS study: Researching the biochemistry of Chronic Fatigue Syndrome

READ MORE

Chronic Fatigue Syndrome can be disabling for sufferers. Despite this, research into it is scarce, and biological reasons for symptoms are poorly understood.

This study will assess brain and muscle biochemistry of participants using magnetic imaging in order to better understand changes that may be related to fatigue.

The study is looking for people who have a diagnosis of Chronic Fatigue Syndrome and who are over 18 years old. The study will involve 1 remote screening discussion and 1 in-person visit to the research site at the University of Oxford which will involve an MRI scan. You will receive £50 for participation.

Study For

Adults who have a diagnosis of Chronic Fatigue Syndrome

Sponsored By

University of Oxford

Participants

20

People

Take Part

Deadline:

December 30, 2022

CABIN study: researching new treatment for people with low mood

READ MORE

This study is researching how antidepressants and behavioural therapy affect people who are experiencing low mood. The study hopes to develop better personalised treatment for low mood.

The study is looking for people who are feeling low in mood but who are not currently taking any medication to treat depression or receiving any type of psychological therapy. The study will involve 6 research visits, 1 in person at the research site at the University of Oxford and 5 online. You will receive £150 for participation.

Study For

Adults with low mood, who are not currently receiving any medication or therapy.

Sponsored By

University of Oxford

Participants

135

People

Take Part

Deadline:

September 1, 2022

PAX-D study: treatment resistant depression

READ MORE

The purpose of this study is to find out if pramipexole is a useful treatment for treatment resistant depression (TRD). A significant proportion of people diagnosed with clinical depression (up to 3 in 10) do not improve with current first-line treatments and are regarded as having TRD. Current medicines for TRD are not particularly effective for many people and often have unwanted effects which may be distressing.

There is some evidence that pramipexole may be an effective treatment for TRD. Pramipexole is unlike current antidepressant drugs in that it acts like a brain chemical called dopamine, which is known to influence people’s motivation to pursue goals and affects how rewarding they find them. This study will require visits to Oxford.

Study For

Adults with treatment resistant depression

Sponsored By

University of Oxford

Participants

204

People

Take Part

Deadline:

December 31, 2022

APEX study: helping to understand asthma attacks

READ MORE

This study is investigating asthma attacks. The research team are looking for people with asthma of any severity.

You will be joining ground-breaking research into understanding asthma attacks and the information the team learns from your participation could help to discover new, potentially lifesaving treatments for asthma patients in the future. It may also help you to better understand and cope with your asthma.

You will be free to withdraw from the study at any time without your legal or medical rights being affected. The information collected during the study will be strictly confidential.

Study For

Adults with asthma

Sponsored By

University of Nottingham

Participants

200

People

Take Part

Deadline:

December 31, 2022

RELAKS: Study researching effects of Ketamine

READ MORE

This research study is looking to investigate the effects of ketamine, particularly how ketamine could affect people’s performance on decision making tasks involving learning and memory. There will be a total of 4 visits, including an infusion visit during which participants will be given either ketamine or a placebo. Research is being conducted by the University of Oxford.

You will receive £250 for taking part in the study and any reasonable travel expenses will also be covered.

Study For

Healthy adults aged 18-45

Sponsored By

University of Oxford

Participants

70

People

Take Part

Deadline:

December 30, 2022

RAPID Study: Investigating new treatment for diabetic foot ulcers

READ MORE

This study is investigating a new treatment for diabetic foot ulcers, the RAPID™ Biodynamic Haematogel. This innovative treatment uses a concentrated gel, containing vitamin C and your body’s own blood cells, to boost the natural healing process. RAPID™ Gel treatments have been clinically validated to be safe and effective and this study is seeking to demonstrate the effectiveness of this treatment on diabetic foot ulcers.

Participants will either receive the new treatment or best in class standard care. All participants will have weekly appointments for 12 weeks, with a final check-up after 6 months. At each weekly appointment, wounds will be reviewed and photographed.

Study For

Adults with a diabetic foot ulcer that has not healed for at least 10 weeks

Sponsored By

Biotherapy Services & NHS Leicestershire

Participants

60

People

Take Part

Deadline:

December 30, 2022

Frequently Asked Questions

What is a clinical trial?

A clinical trial is a medical study comparing the effect of different healthcare treatments. They are essential for finding new, safer and more effective treatments for all kinds of health conditions.

Will I be paid for participating in research?

Most trials and studies will cover your travel expenses and other expenses you may incur from participation. Some offer additional compensation. Full details of compensation can be found on the relevant study page.

Who can take part in a clinical trial or study?

Every clinical trial has unique requirements for taking part, called the ‘inclusion’ and ‘exclusion’ criteria. If you don't qualify for one trial you're interested in, you may qualify for another in your area. You can also fill out your profile here to sign up for alerts from Lindus Health when new trials match your profile.

Is it safe to take part in a clinical trial?

Yes. The safety of participants is very important. Before any clinical trial can begin, plans must be approved by medical regulators and ethics committees. All participants in clinical trials are under the care of the trial teams, who must include qualified doctors and clinicians. The care they receive must be at least as good as care received by the general population.

Can I change my mind about taking part?

Yes, you can still leave a clinical trial at any time, for any reason.

How much time does it take to participate in a trial or study?

Time commitment varies across clinical trials. Full details of time commitments are available on the study page, or you can ask the study staff.

What is a control arm or placebo?

A ‘control arm’ or ‘placebo’ is often used to fairly assess how effective a treatment is. In some clinical trials, up to half the participants may receive an existing treatment or a placebo (a dummy treatment). The results of these participants are compared against the participants who had the new treatment. This helps remove bias and fairly assess how well the new treatment works.

What do you do with my data?

We ask for your permission before collecting and storing any of your data, and sharing it with the study teams. All results are completely confidential. For full details, please see our privacy policy. Volunteers for clinical trials and studies are essential to moving healthcare forward. If you're ready to get involved, start searching for a trial that matches you today.

If you have more question. We're happy to help!

Contact Us

Couldn't find a trial for you right now?

Join our community so we can share the most relevant research opportunities with you directly
Join our community